Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Direct
Mintz Viewpoints
Showing 10489 - 10496 of 12008 results
Privacy & Security Bits and Bytes
April 18, 2014| Blog| Viewpoint
New Swap Business Conduct and Record-Keeping Regulations Kick in for Municipal Bond Issuers and Borrowers
April 18, 2014| Alert| Viewpoint
Target Becomes a Target: Proposed California Bill Aims to Make Retailers Liable for Data Breach Incidents
April 17, 2014| Blog| Viewpoint
4th Circuit Unmasks Company Doe & Unseals Entire Record in CPSC Database Case
April 17, 2014| Blog| Viewpoint
It’s The End of the World as We Know It: Life after Non-Competes in Massachusetts (Why You Should Feel Fine)
April 17, 2014| Blog| Viewpoint
Is 4-3 the New 3-2? FTC Continues to Target Pharmaceutical Mergers
April 16, 2014| Alert| Viewpoint
ML Strategies Posts Weekly Health Care Update on April 14, 2014
April 15, 2014| Blog| Viewpoint
Unified Residency Accreditation System To Be Launched
April 14, 2014| Blog| Viewpoint
News & Press Releases
Mintz advised The Eagle Leasing Company, a leading provider of portable storage containers, ground level offices, semi-trailers, and mobile office solutions, in its acquisition by Rent-A-Container (RAC), a portfolio company of Kinderhook Industries, LLC.
Mintz’s Life Sciences practice has been shortlisted in multiple categories for the 2025 LMG Life Sciences Americas Awards. The winners will be announced at an awards ceremony in New York on September 4. In the United States, Mintz was shortlisted in the “Venture Capital Firm of the Year” category. In Canada, Mintz was shortlisted in the “Financial & Corporate Firm of the Year” and “Patent Strategy Firm of the Year” categories.
Mintz advised ArriVent BioPharma, Inc., a clinical-stage biopharmaceutical company dedicated to the identification, development, and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers, on a $75 million underwritten public offering of 2,482,692 shares of its common stock and pre-funded warrants to purchase up to 1,363,469 shares of its common stock. The common stock is listed on The Nasdaq Global Market under the symbol “AVBP.“
Events
Mintz x The Engine: Supercharging Your IP Strategy with Trade Secrets
The Engine, 750 Main St. Cambridge, MA 02139
Podcasts
Health Law Diagnosed – Best Practices for Communicating with the FDA
July 9, 2025| Podcast|
Mintz On Air: Practical Policies – An Abridged Guide to Crisis Management
July 1, 2025| Podcast|